| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.766 | 93.668 | 92.380 | 91.158 | 89.904 | 77.951 | 85.966 | 146.411 | 134.332 | 119.583 |
| Total Income - EUR | 51.720 | 94.003 | 92.502 | 91.246 | 89.981 | 78.207 | 85.966 | 320.895 | 134.795 | 120.304 |
| Total Expenses - EUR | 30.048 | 25.777 | 37.926 | 32.867 | 32.738 | 35.231 | 48.716 | 159.902 | 83.024 | 66.025 |
| Gross Profit/Loss - EUR | 21.672 | 68.225 | 54.575 | 58.379 | 57.243 | 42.977 | 37.251 | 160.993 | 51.770 | 54.279 |
| Net Profit/Loss - EUR | 17.337 | 65.405 | 53.357 | 57.466 | 56.344 | 42.251 | 36.737 | 158.117 | 50.609 | 45.925 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Galenus Farmacie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 128.114 | 116.749 | 124.293 | 138.464 | 116.519 | 219.636 | 196.776 | 331.234 | 350.141 | 567.528 |
| Current Assets | 9.232 | 15.202 | 9.341 | 12.884 | 58.074 | 14.734 | 20.079 | 268.058 | 169.595 | 27.373 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 6.616 | 12.850 | 46.258 | 54.207 | 0 |
| Receivables | 3.545 | 14.502 | 8.718 | 12.527 | 57.468 | 7.749 | 6.551 | 120.804 | 23.180 | 26.836 |
| Cash | 5.687 | 700 | 623 | 357 | 606 | 368 | 679 | 100.997 | 92.208 | 537 |
| Shareholders Funds | 27.972 | 65.486 | 53.437 | 57.545 | 56.421 | 49.244 | 84.890 | 158.191 | 168.788 | 225.796 |
| Social Capital | 65 | 65 | 63 | 62 | 61 | 60 | 59 | 59 | 59 | 58 |
| Debts | 109.374 | 66.465 | 28.162 | 41.144 | 64.111 | 185.125 | 131.966 | 152.821 | 159.560 | 274.268 |
| Income in Advance | 0 | 52.720 | 52.036 | 52.659 | 54.062 | 0 | 0 | 288.280 | 191.389 | 94.838 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Galenus Farmacie Srl